Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
P.2.c.001 Efficacy of the novel antidepressant agomelatine for anxiety symptoms within depression — Dan Joseph Stein (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
P.2.c.001 Efficacy of the novel antidepressant agomelatine for anxiety symptoms within depression
Shared by
Dan Joseph Stein
P.2.c.001 Efficacy of the novel antidepressant agomelatine for anxiety symptoms within depression
Article
2011
en
Authors
Dan Joseph Stein
SK
Sidney H. Kennedy
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2013
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
Dan Joseph Stein
,
F. Picarel-Blanchot
,
Sidney H. Kennedy
Article
2020
P.095 Efficacy of agomelatine for anxiety symptoms in adult patients with major depressive disorder
Dan Joseph Stein
,
Damien Chimits
,
F. Picarel-Blanchot
,
Jon‐Paul Khoo
Article
2008
Efficacy of Agomelatine in Generalized Anxiety Disorder
Dan Joseph Stein
,
Antti Ahokas
,
Christian de Bodinat
Article
2021
Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
Dan Joseph Stein
,
Jon‐Paul Khoo
,
F. Picarel-Blanchot
,
Valérie Olivier
,
Michael Van Ameringen
Article
2023
Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine
Dan Joseph Stein
Discussion(0)
No comments yet. Be the first to comment.